| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $9.1M | -8.0% |
| Cost of Revenue | $5.3M | -48.7% |
| R&D Expense | $3.0M | -31.8% |
| SG&A Expense | $9.8M | -43.3% |
| Operating Income | -$10.4M | +67.2% |
| Interest Expense | $159K | +435.2% |
| Pre-tax Income | -$25.6M | +25.2% |
| Net Income | -$25.6M | +25.2% |
| EPS (Basic) | -$51.84 |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Short-term Investments | $298K | +0.0% |
| Accounts Receivable | $201K | +3.3% |
| Current Assets | $3.0M | -40.4% |
| Total Assets | $5.4M | -41.6% |
| Current Liabilities | $29.5M | -5.7% |
| Long-term Debt | $2.9M | +0.0% |
| Total Liabilities | $30.7M | -28.4% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.1M | +59.1% |
| Investing Cash Flow | $492K | — |
| Financing Cash Flow | $8.3M | -59.1% |
| -2428.8% |
| EPS (Diluted) | -$51.84 | -2428.8% |
| Stockholders' Equity |
| -$25.3M |
| +24.8% |